Sandbox g08
Jump to navigation
Jump to search
| Adenosine Deaminase | [Chemical/Ingredient] |
| Adenovirus Vaccines | [Chemical/Ingredient] |
| Adrenocorticotropic Hormone | [Chemical/Ingredient] |
| Allergens | [Chemical/Ingredient] |
| Allylamine | [Chemical/Ingredient] |
| alpha-Glucosidases | [Chemical/Ingredient] |
| Amides | [Chemical/Ingredient] |
| Amino Acids | [Chemical/Ingredient] |
| Aminoglycosides | [Chemical/Ingredient] |
| Aminosalicylic Acids | [Chemical/Ingredient] |
| Amphenicols | [Chemical/Ingredient] |
| Amphetamines | [Chemical/Ingredient] |
| Analogs/Derivatives | [Chemical/Ingredient] |
| Androstanes | [Chemical/Ingredient] |
| Ant Venoms | [Chemical/Ingredient] |
| Anthracyclines | [Chemical/Ingredient] |
| Antibodies, Monoclonal | [Chemical/Ingredient] |
| Antigens, Bacterial | [Chemical/Ingredient] |
| Antigens, Dermatophagoides | [Chemical/Ingredient] |
| Antigens, Fungal | [Chemical/Ingredient] |
| Antitoxins | [Chemical/Ingredient] |
| Antivenins | [Chemical/Ingredient] |
| Aptamers, Nucleotide | [Chemical/Ingredient] |
| Asparaginase | [Chemical/Ingredient] |
| Azoles | [Chemical/Ingredient] |
| Bacterial Proteins | [Chemical/Ingredient] |
| Barbiturates | [Chemical/Ingredient] |
| BCG Vaccine | [Chemical/Ingredient] |
| Bee Venoms | [Chemical/Ingredient] |
| Benzodiazepines | [Chemical/Ingredient] |
| Benzothiazoles | [Chemical/Ingredient] |
| Benzylamines | [Chemical/Ingredient] |
| Biguanides | [Chemical/Ingredient] |
| Bile Acids and Salts | [Chemical/Ingredient] |
| Bismuth | [Chemical/Ingredient] |
| Blood Coagulation Factors | [Chemical/Ingredient] |
| Boron Compounds | [Chemical/Ingredient] |
| Calcitonin | [Chemical/Ingredient] |
| Calcium | [Chemical/Ingredient] |
| Cannabinoids | [Chemical/Ingredient] |
| Carbapenems | [Chemical/Ingredient] |
| Carbon Radioisotopes | [Chemical/Ingredient] |
| Cardiac Glycosides | [Chemical/Ingredient] |
| Carnitine | [Chemical/Ingredient] |
| Caseins | [Chemical/Ingredient] |
| Catecholamines | [Chemical/Ingredient] |
| Cations, Divalent | [Chemical/Ingredient] |
| Cells, Allogeneic | [Chemical/Ingredient] |
| Cells, Cultured, Allogeneic | [Chemical/Ingredient] |
| Cells, Cultured, Autologous | [Chemical/Ingredient] |
| Cells, Epidermal | [Chemical/Ingredient] |
| Cephalosporins | [Chemical/Ingredient] |
| Cholecalciferol | [Chemical/Ingredient] |
| Cholecystokinin | [Chemical/Ingredient] |
| Chondrocytes | [Chemical/Ingredient] |
| Collagen | [Chemical/Ingredient] |
| Collagenases | [Chemical/Ingredient] |
| Copper | [Chemical/Ingredient] |
| Dander | [Chemical/Ingredient] |
| Deoxyribonuclease I | [Chemical/Ingredient] |
| Deoxyuridine | [Chemical/Ingredient] |
| Diarylquinolines | [Chemical/Ingredient] |
| Dietary Proteins | [Chemical/Ingredient] |
| Dihydropyridines | [Chemical/Ingredient] |
| Diphosphonates | [Chemical/Ingredient] |
| Diphtheria Toxin | [Chemical/Ingredient] |
| Egg Proteins, Dietary | [Chemical/Ingredient] |
| Enzyme Precursors | [Chemical/Ingredient] |
| Ergocalciferols | [Chemical/Ingredient] |
| Ergolines | [Chemical/Ingredient] |
| Ergot Alkaloids | [Chemical/Ingredient] |
| Ergotamines | [Chemical/Ingredient] |
| Erythropoietin | [Chemical/Ingredient] |
| Esters | [Chemical/Ingredient] |
| Estradiol Congeners | [Chemical/Ingredient] |
| Estradiol | [Chemical/Ingredient] |
| Estrogens, Conjugated (USP) | [Chemical/Ingredient] |
| Factor VIII | [Chemical/Ingredient] |
| Fatty Acids, Omega-3 | [Chemical/Ingredient] |
| Feathers | [Chemical/Ingredient] |
| Fibroblast Growth Factor 7 | [Chemical/Ingredient] |
| Fibroblasts | [Chemical/Ingredient] |
| Fish Proteins, Dietary | [Chemical/Ingredient] |
| Folic Acid | [Chemical/Ingredient] |
| Food Additives | [Chemical/Ingredient] |
| Fruit Proteins | [Chemical/Ingredient] |
| Fungal Proteins | [Chemical/Ingredient] |
| Fur | [Chemical/Ingredient] |
| Glucagon-Like Peptide 1 | [Chemical/Ingredient] |
| Glucosylceramidase | [Chemical/Ingredient] |
| Glycerol | [Chemical/Ingredient] |
| Glycopeptides | [Chemical/Ingredient] |
| Glycosaminoglycans | [Chemical/Ingredient] |
| Glycoside Hydrolases | [Chemical/Ingredient] |
| Gonadotropins | [Chemical/Ingredient] |
| Grain Proteins | [Chemical/Ingredient] |
| Granulocyte Colony-Stimulating Factor | [Chemical/Ingredient] |
| Granulocyte-Macrophage Colony-Stimulating Factor | [Chemical/Ingredient] |
| Hematopoietic Stem Cells | [Chemical/Ingredient] |
| Heparin | [Chemical/Ingredient] |
| Heparin, Low-Molecular-Weight | [Chemical/Ingredient] |
| House Dust | [Chemical/Ingredient] |
| Immunoconjugates | [Chemical/Ingredient] |
| Immunoglobulins | [Chemical/Ingredient] |
| Insect Proteins | [Chemical/Ingredient] |
| Insulin | [Chemical/Ingredient] |
| Interferon Alfa-2b | [Chemical/Ingredient] |
| Interferon-alpha | [Chemical/Ingredient] |
| Interferon-beta | [Chemical/Ingredient] |
| Interferon-gamma | [Chemical/Ingredient] |
| Interleukin-2 | [Chemical/Ingredient] |
| Iodine | [Chemical/Ingredient] |
| Iron | [Chemical/Ingredient] |
| Keratinocytes | [Chemical/Ingredient] |
| Ketolides | [Chemical/Ingredient] |
| Leptin | [Chemical/Ingredient] |
| Lincosamides | [Chemical/Ingredient] |
| Lipids | [Chemical/Ingredient] |
| Lipoglycopeptides | [Chemical/Ingredient] |
| Lipopeptides | [Chemical/Ingredient] |
| Macrolides | [Chemical/Ingredient] |
| Meat Proteins | [Chemical/Ingredient] |
| Methylated Sulfonamides | [Chemical/Ingredient] |
| Milk Proteins | [Chemical/Ingredient] |
| Monobactams | [Chemical/Ingredient] |
| Mumps Vaccine | [Chemical/Ingredient] |
| N-substituted Glycines | [Chemical/Ingredient] |
| Natriuretic Peptides | [Chemical/Ingredient] |
| Nicotine | [Chemical/Ingredient] |
| Nicotinic Acids | [Chemical/Ingredient] |
| Nitrates | [Chemical/Ingredient] |
| Nitrofurans | [Chemical/Ingredient] |
| Nitrogen Mustard Compounds | [Chemical/Ingredient] |
| Nitroimidazoles | [Chemical/Ingredient] |
| Non-Nucleoside Analog | [Chemical/Ingredient] |
| Nonsteroidal Anti-inflammatory Compounds | [Chemical/Ingredient] |
| Nucleoside Analog | [Chemical/Ingredient] |
| Nut Proteins | [Chemical/Ingredient] |
| Oligonucleotides | [Chemical/Ingredient] |
| Organometallic Compounds | [Chemical/Ingredient] |
| Oxazolidinones | [Chemical/Ingredient] |
| Oxytocin | [Chemical/Ingredient] |
| Parathyroid Hormone | [Chemical/Ingredient] |
| peginterferon alfa-2a | [Chemical/Ingredient] |
| peginterferon alfa-2b | [Chemical/Ingredient] |
| Penicillins | [Chemical/Ingredient] |
| Peripheral Blood Mononuclear Cells | [Chemical/Ingredient] |
| Phenothiazines | [Chemical/Ingredient] |
| Plant Proteins | [Chemical/Ingredient] |
| Platelet-Derived Growth Factor | [Chemical/Ingredient] |
| Platinum-containing Compounds | [Chemical/Ingredient] |
| pleuromutilin | [Chemical/Ingredient] |
| Pollen | [Chemical/Ingredient] |
| Polyenes | [Chemical/Ingredient] |
| Polymyxins | [Chemical/Ingredient] |
| Porphyrinogens | [Chemical/Ingredient] |
| Potassium Compounds | [Chemical/Ingredient] |
| Poultry Proteins | [Chemical/Ingredient] |
| PPAR alpha | [Chemical/Ingredient] |
| PPAR gamma | [Chemical/Ingredient] |
| Progesterone Congeners | [Chemical/Ingredient] |
| Progesterone | [Chemical/Ingredient] |
| Prostaglandins E, Synthetic | [Chemical/Ingredient] |
| Prostaglandins I | [Chemical/Ingredient] |
| Prostaglandins | [Chemical/Ingredient] |
| Protein C | [Chemical/Ingredient] |
| Psoralens | [Chemical/Ingredient] |
| Purines | [Chemical/Ingredient] |
| Pyrethrins | [Chemical/Ingredient] |
| Pyridones | [Chemical/Ingredient] |
| Pyrophosphate Analog | [Chemical/Ingredient] |
| Quaternary Ammonium Compounds | [Chemical/Ingredient] |
| Quinolones | [Chemical/Ingredient] |
| Radioactive Tracers | [Chemical/Ingredient] |
| Recombinant Fusion Proteins | [Chemical/Ingredient] |
| Recombinant Human Growth Hormones | [Chemical/Ingredient] |
| Recombinant Proteins | [Chemical/Ingredient] |
| Retinoids | [Chemical/Ingredient] |
| Rifamycins | [Chemical/Ingredient] |
| Rotavirus Vaccines | [Chemical/Ingredient] |
| Salivary Proteins and Peptides | [Chemical/Ingredient] |
| Seed Storage Proteins | [Chemical/Ingredient] |
| Serum Albumin | [Chemical/Ingredient] |
| Shellfish Proteins | [Chemical/Ingredient] |
| Silk | [Chemical/Ingredient] |
| Starch | [Chemical/Ingredient] |
| Streptogramins | [Chemical/Ingredient] |
| Sulfonamides | [Chemical/Ingredient] |
| Sulfones | [Chemical/Ingredient] |
| Sulfonylurea Compounds | [Chemical/Ingredient] |
| Tetracyclines | [Chemical/Ingredient] |
| Thiazides | [Chemical/Ingredient] |
| Thiazolidinediones | [Chemical/Ingredient] |
| Thrombopoietin | [Chemical/Ingredient] |
| Thyrotropin | [Chemical/Ingredient] |
| Thyroxine | [Chemical/Ingredient] |
| Tissue Scaffolds | [Chemical/Ingredient] |
| Transglutaminases | [Chemical/Ingredient] |
| Triiodothyronine | [Chemical/Ingredient] |
| Urate Oxidase | [Chemical/Ingredient] |
| Urea | [Chemical/Ingredient] |
| Vaccines, Attenuated | [Chemical/Ingredient] |
| Vaccines, Inactivated | [Chemical/Ingredient] |
| Vaccines, Live, Unattenuated | [Chemical/Ingredient] |
| Vaccines, Typhoid | [Chemical/Ingredient] |
| Vasopressins | [Chemical/Ingredient] |
| Vegetable Proteins | [Chemical/Ingredient] |
| Vi polysaccharide vaccine, typhoid | [Chemical/Ingredient] |
| Vinca Alkaloids | [Chemical/Ingredient] |
| Virus-specific Hyperimmune Globulins | [Chemical/Ingredient] |
| Vitamin A | [Chemical/Ingredient] |
| Vitamin B 12 | [Chemical/Ingredient] |
| Vitamin B Complex Compounds | [Chemical/Ingredient] |
| Vitamin D | [Chemical/Ingredient] |
| Vitamin K | [Chemical/Ingredient] |
| von Willebrand Factor | [Chemical/Ingredient] |
| Wasp Venoms | [Chemical/Ingredient] |
| Xanthines | [Chemical/Ingredient] |
| 5-alpha Reductase Inhibitor | [FDA Established Pharmacologic Classes] |
| 5-Lipoxygenase Inhibitor | [FDA Established Pharmacologic Classes] |
| Acetylcholine Release Inhibitor | [FDA Established Pharmacologic Classes] |
| Acetylcholine Releasing Agent | [FDA Established Pharmacologic Classes] |
| Actinomycin | [FDA Established Pharmacologic Classes] |
| Adenosine Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Adrenal Steroid Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
| Adrenergic Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Adrenocorticotropic Hormone | [FDA Established Pharmacologic Classes] |
| Aldehyde Dehydrogenase Inhibitor | [FDA Established Pharmacologic Classes] |
| Aldosterone Antagonist | [FDA Established Pharmacologic Classes] |
| Alkylating Drug | [FDA Established Pharmacologic Classes] |
| Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy | [FDA Established Pharmacologic Classes] |
| Allogeneic Cultured Cell Scaffold | [FDA Established Pharmacologic Classes] |
| Allylamine Antifungal | [FDA Established Pharmacologic Classes] |
| alpha-1 Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
| alpha-Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
| alpha-Adrenergic Blocker | [FDA Established Pharmacologic Classes] |
| alpha-Glucosidase Inhibitor | [FDA Established Pharmacologic Classes] |
| Aluminum Complex | [FDA Established Pharmacologic Classes] |
| Amide Local Anesthetic | [FDA Established Pharmacologic Classes] |
| Amino Acid Hypertonic Solution | [FDA Established Pharmacologic Classes] |
| Amino Acid | [FDA Established Pharmacologic Classes] |
| Aminoglycoside Antibacterial | [FDA Established Pharmacologic Classes] |
| Aminoketone | [FDA Established Pharmacologic Classes] |
| Aminosalicylate | [FDA Established Pharmacologic Classes] |
| Amphenicol-class Antibacterial | [FDA Established Pharmacologic Classes] |
| Amphetamine Anorectic | [FDA Established Pharmacologic Classes] |
| Amylin Analog | [FDA Established Pharmacologic Classes] |
| Androgen Receptor Inhibitor | [FDA Established Pharmacologic Classes] |
| Androgen | [FDA Established Pharmacologic Classes] |
| Angiotensin 2 Receptor Blocker | [FDA Established Pharmacologic Classes] |
| Angiotensin Converting Enzyme Inhibitor | [FDA Established Pharmacologic Classes] |
| Anthracycline Topoisomerase Inhibitor | [FDA Established Pharmacologic Classes] |
| Anti-anginal | [FDA Established Pharmacologic Classes] |
| Anti-coagulant | [FDA Established Pharmacologic Classes] |
| Anti-epileptic Agent | [FDA Established Pharmacologic Classes] |
| Anti-IgE | [FDA Established Pharmacologic Classes] |
| Anti-inhibitor Coagulant Complex | [FDA Established Pharmacologic Classes] |
| Antiarrhythmic | [FDA Established Pharmacologic Classes] |
| Anticholinergic | [FDA Established Pharmacologic Classes] |
| Antidiarrheal | [FDA Established Pharmacologic Classes] |
| Antidote for Acetaminophen Overdose | [FDA Established Pharmacologic Classes] |
| Antidote | [FDA Established Pharmacologic Classes] |
| Antiemetic | [FDA Established Pharmacologic Classes] |
| Antifibrinolytic Agent | [FDA Established Pharmacologic Classes] |
| Antihelminthic | [FDA Established Pharmacologic Classes] |
| Antihistamine | [FDA Established Pharmacologic Classes] |
| Antihypoglycemic Agent | [FDA Established Pharmacologic Classes] |
| Antileishmanial | [FDA Established Pharmacologic Classes] |
| Antimalarial | [FDA Established Pharmacologic Classes] |
| Antimetabolite Immunosuppressant | [FDA Established Pharmacologic Classes] |
| Antimetabolite | [FDA Established Pharmacologic Classes] |
| Antimycobacterial | [FDA Established Pharmacologic Classes] |
| Antiparasitic | [FDA Established Pharmacologic Classes] |
| Antiprotozoal | [FDA Established Pharmacologic Classes] |
| Antirheumatic Agent | [FDA Established Pharmacologic Classes] |
| Antiseptic | [FDA Established Pharmacologic Classes] |
| Antivenin | [FDA Established Pharmacologic Classes] |
| Aromatase Inhibitor | [FDA Established Pharmacologic Classes] |
| Aromatic Amino Acid Decarboxylation Inhibitor | [FDA Established Pharmacologic Classes] |
| Arteriolar Vasodilator | [FDA Established Pharmacologic Classes] |
| Asparagine-specific Enzyme | [FDA Established Pharmacologic Classes] |
| Atypical Antipsychotic | [FDA Established Pharmacologic Classes] |
| Autologous Cellular Immunotherapy | [FDA Established Pharmacologic Classes] |
| Autologous Cultured Cell | [FDA Established Pharmacologic Classes] |
| Autonomic Ganglionic Blocker | [FDA Established Pharmacologic Classes] |
| Azole Antifungal | [FDA Established Pharmacologic Classes] |
| B Lymphocyte Stimulator-specific Inhibitor | [FDA Established Pharmacologic Classes] |
| Barbiturate | [FDA Established Pharmacologic Classes] |
| Benzodiazepine Antagonist | [FDA Established Pharmacologic Classes] |
| Benzodiazepine | [FDA Established Pharmacologic Classes] |
| Benzothiazole | [FDA Established Pharmacologic Classes] |
| Benzylamine Antifungal | [FDA Established Pharmacologic Classes] |
| beta Lactamase Inhibitor | [FDA Established Pharmacologic Classes] |
| beta-Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
| beta-Adrenergic Blocker | [FDA Established Pharmacologic Classes] |
| beta2-Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
| beta3-Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
| Biguanide | [FDA Established Pharmacologic Classes] |
| Bile Acid Sequestrant | [FDA Established Pharmacologic Classes] |
| Bile Acid | [FDA Established Pharmacologic Classes] |
| Bismuth | [FDA Established Pharmacologic Classes] |
| Bisphosphonate | [FDA Established Pharmacologic Classes] |
| Blood Coagulation Factor | [FDA Established Pharmacologic Classes] |
| Blood Viscosity Reducer | [FDA Established Pharmacologic Classes] |
| Bovine Intestinal Adenosine Deaminase | [FDA Established Pharmacologic Classes] |
| Bradykinin B2 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Calcineurin Inhibitor Immunosuppressant | [FDA Established Pharmacologic Classes] |
| Calcitonin | [FDA Established Pharmacologic Classes] |
| Calcium Channel Blocker | [FDA Established Pharmacologic Classes] |
| Calcium | [FDA Established Pharmacologic Classes] |
| Calcium-sensing Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Calculi Dissolution Agent | [FDA Established Pharmacologic Classes] |
| Cannabinoid | [FDA Established Pharmacologic Classes] |
| Carbamoyl Phosphate Synthetase 1 Activator | [FDA Established Pharmacologic Classes] |
| Carbonic Anhydrase Inhibitor | [FDA Established Pharmacologic Classes] |
| Cardiac Glycoside | [FDA Established Pharmacologic Classes] |
| Carnitine Analog | [FDA Established Pharmacologic Classes] |
| Catechol-O-Methyltransferase Inhibitor | [FDA Established Pharmacologic Classes] |
| Catecholamine Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
| Catecholamine | [FDA Established Pharmacologic Classes] |
| Catecholamine-depleting Sympatholytic | [FDA Established Pharmacologic Classes] |
| CCR5 Co-receptor Antagonist | [FDA Established Pharmacologic Classes] |
| CD20-directed Cytolytic Antibody | [FDA Established Pharmacologic Classes] |
| CD20-directed Radiotherapeutic Antibody | [FDA Established Pharmacologic Classes] |
| CD25-directed Cytotoxin | [FDA Established Pharmacologic Classes] |
| CD3 Blocker Immunosuppressant | [FDA Established Pharmacologic Classes] |
| CD30-directed Immunoconjugate | [FDA Established Pharmacologic Classes] |
| CD52-directed Cytolytic Antibody | [FDA Established Pharmacologic Classes] |
| Cell Death Inducer | [FDA Established Pharmacologic Classes] |
| Central alpha-2 Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
| Central Nervous System Depressant | [FDA Established Pharmacologic Classes] |
| Central Nervous System Stimulant | [FDA Established Pharmacologic Classes] |
| Cephalosporin Antibacterial | [FDA Established Pharmacologic Classes] |
| Chloride Channel Activator | [FDA Established Pharmacologic Classes] |
| Cholecystokinin Analog | [FDA Established Pharmacologic Classes] |
| Cholinergic Muscarinic Agonist | [FDA Established Pharmacologic Classes] |
| Cholinergic Muscarinic Antagonist | [FDA Established Pharmacologic Classes] |
| Cholinergic Nicotinic Agonist | [FDA Established Pharmacologic Classes] |
| Cholinergic Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Cholinesterase Inhibitor | [FDA Established Pharmacologic Classes] |
| Cholinesterase Reactivator | [FDA Established Pharmacologic Classes] |
| Collagen-specific Enzyme | [FDA Established Pharmacologic Classes] |
| Complement Inhibitor | [FDA Established Pharmacologic Classes] |
| Contrast Agent for Ultrasound Imaging | [FDA Established Pharmacologic Classes] |
| Copper Absorption Inhibitor | [FDA Established Pharmacologic Classes] |
| Copper-containing Intrauterine Device | [FDA Established Pharmacologic Classes] |
| Corticosteroid | [FDA Established Pharmacologic Classes] |
| CTLA-4-directed Blocking Antibody | [FDA Established Pharmacologic Classes] |
| Cystic Fibrosis Transmembrane Conductance Regulator Potentiator | [FDA Established Pharmacologic Classes] |
| Cystine Depleting Agent | [FDA Established Pharmacologic Classes] |
| Cytochrome P450 17A1 Inhibitor | [FDA Established Pharmacologic Classes] |
| Cytochrome P450 2D6 Inhibitor | [FDA Established Pharmacologic Classes] |
| Cytochrome P450 3A Inhibitor | [FDA Established Pharmacologic Classes] |
| Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
| Cytoprotective Agent | [FDA Established Pharmacologic Classes] |
| Decarboxylase Inhibitor | [FDA Established Pharmacologic Classes] |
| Demulcent | [FDA Established Pharmacologic Classes] |
| Depigmenting Agent | [FDA Established Pharmacologic Classes] |
| Depolarizing Neuromuscular Blocker | [FDA Established Pharmacologic Classes] |
| Diagnostic Dye | [FDA Established Pharmacologic Classes] |
| Diarylquinoline Antimycobacterial | [FDA Established Pharmacologic Classes] |
| Dietary Cholesterol Absorption Inhibitor | [FDA Established Pharmacologic Classes] |
| Dihydrofolate Reductase Inhibitor Antibacterial | [FDA Established Pharmacologic Classes] |
| Dihydrofolate Reductase Inhibitor Antimalarial | [FDA Established Pharmacologic Classes] |
| Dihydropyridine Calcium Channel Blocker | [FDA Established Pharmacologic Classes] |
| Dipeptidyl Peptidase 4 Inhibitor | [FDA Established Pharmacologic Classes] |
| Direct Thrombin Inhibitor | [FDA Established Pharmacologic Classes] |
| Dopamine-2 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Dopaminergic Agonist | [FDA Established Pharmacologic Classes] |
| Echinocandin Antifungal | [FDA Established Pharmacologic Classes] |
| Endoglycosidase | [FDA Established Pharmacologic Classes] |
| Endothelin Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Epidermal Growth Factor Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Ergot Derivative | [FDA Established Pharmacologic Classes] |
| Ergot-derived Dopamine Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Ergotamine Derivative | [FDA Established Pharmacologic Classes] |
| Erythropoiesis-stimulating Agent | [FDA Established Pharmacologic Classes] |
| Ester Local Anesthetic | [FDA Established Pharmacologic Classes] |
| Estrogen Agonist/Antagonist | [FDA Established Pharmacologic Classes] |
| Estrogen Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Estrogen | [FDA Established Pharmacologic Classes] |
| Factor VIII Activator | [FDA Established Pharmacologic Classes] |
| Factor Xa Inhibitor | [FDA Established Pharmacologic Classes] |
| Folate Analog Metabolic Inhibitor | [FDA Established Pharmacologic Classes] |
| Folate Analog | [FDA Established Pharmacologic Classes] |
| Gadolinium-based Contrast Agent | [FDA Established Pharmacologic Classes] |
| gamma-Aminobutyric Acid A Receptor Agonist | [FDA Established Pharmacologic Classes] |
| gamma-Aminobutyric Acid-ergic Agonist | [FDA Established Pharmacologic Classes] |
| Gastrointestinal Motility Inhibitor | [FDA Established Pharmacologic Classes] |
| General Anesthetic | [FDA Established Pharmacologic Classes] |
| Glinide | [FDA Established Pharmacologic Classes] |
| GLP-1 Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Glucosylceramide Synthase Inhibitor | [FDA Established Pharmacologic Classes] |
| Glycopeptide Antibacterial | [FDA Established Pharmacologic Classes] |
| Glycosaminoglycan | [FDA Established Pharmacologic Classes] |
| Gonadotropin Releasing Hormone Antagonist | [FDA Established Pharmacologic Classes] |
| Gonadotropin Releasing Hormone Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Gonadotropin | [FDA Established Pharmacologic Classes] |
| Growth Hormone Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Growth Hormone Releasing Factor Analog | [FDA Established Pharmacologic Classes] |
| Guanylate Cyclase-C Agonist | [FDA Established Pharmacologic Classes] |
| Hedgehog Pathway Inhibitor | [FDA Established Pharmacologic Classes] |
| Helicobacter pylori Diagnostic | [FDA Established Pharmacologic Classes] |
| Hematopoietic Stem Cell Mobilizer | [FDA Established Pharmacologic Classes] |
| Heparin Reversal Agent | [FDA Established Pharmacologic Classes] |
| Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor | [FDA Established Pharmacologic Classes] |
| Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
| Hepatitis C Virus NS3/4A Protease Inhibitor | [FDA Established Pharmacologic Classes] |
| Hepatitis C Virus NS5A Inhibitor | [FDA Established Pharmacologic Classes] |
| HER2 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
| Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
| Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
| Histamine-1 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Histamine-1 Receptor Inhibitor | [FDA Established Pharmacologic Classes] |
| Histamine-2 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Histone Deacetylase Inhibitor | [FDA Established Pharmacologic Classes] |
| HMG-CoA Reductase Inhibitor | [FDA Established Pharmacologic Classes] |
| Human alpha-1 Proteinase Inhibitor | [FDA Established Pharmacologic Classes] |
| Human Antihemophilic Factor | [FDA Established Pharmacologic Classes] |
| Human Blood Coagulation Factor | [FDA Established Pharmacologic Classes] |
| Human C1 Esterase Inhibitor | [FDA Established Pharmacologic Classes] |
| Human Immunodeficiency Virus 1 Fusion Inhibitor | [FDA Established Pharmacologic Classes] |
| Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor | [FDA Established Pharmacologic Classes] |
| Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor | [FDA Established Pharmacologic Classes] |
| Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor | [FDA Established Pharmacologic Classes] |
| Human Immunoglobulin G | [FDA Established Pharmacologic Classes] |
| Human Immunoglobulin | [FDA Established Pharmacologic Classes] |
| Human Platelet-derived Growth Factor | [FDA Established Pharmacologic Classes] |
| Human Serum Albumin | [FDA Established Pharmacologic Classes] |
| Hydrolytic Lysosomal Glucocerebroside-specific Enzyme | [FDA Established Pharmacologic Classes] |
| Hydrolytic Lysosomal Glycogen-specific Enzyme | [FDA Established Pharmacologic Classes] |
| Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme | [FDA Established Pharmacologic Classes] |
| Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme | [FDA Established Pharmacologic Classes] |
| Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor | [FDA Established Pharmacologic Classes] |
| Immunoglobulin G | [FDA Established Pharmacologic Classes] |
| Inactivated Salmonella Typhi Vaccine | [FDA Established Pharmacologic Classes] |
| Influenza A M2 Protein Inhibitor | [FDA Established Pharmacologic Classes] |
| Inhalation Diagnostic Agent | [FDA Established Pharmacologic Classes] |
| Insulin Analog | [FDA Established Pharmacologic Classes] |
| Insulin | [FDA Established Pharmacologic Classes] |
| Integrin Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Interferon alpha | [FDA Established Pharmacologic Classes] |
| Interferon gamma | [FDA Established Pharmacologic Classes] |
| Interleukin-1 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Interleukin-2 Receptor Blocking Antibody | [FDA Established Pharmacologic Classes] |
| Interleukin-6 Antagonist | [FDA Established Pharmacologic Classes] |
| Interleukin-6 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Intestinal Lipase Inhibitor | [FDA Established Pharmacologic Classes] |
| Iron Chelator | [FDA Established Pharmacologic Classes] |
| Janus Kinase Inhibitor | [FDA Established Pharmacologic Classes] |
| Ketolide Antibacterial | [FDA Established Pharmacologic Classes] |
| Kinase Inhibitor | [FDA Established Pharmacologic Classes] |
| l-Thyroxine | [FDA Established Pharmacologic Classes] |
| l-Triiodothyronine | [FDA Established Pharmacologic Classes] |
| Lead Chelator | [FDA Established Pharmacologic Classes] |
| Leptin Analog | [FDA Established Pharmacologic Classes] |
| Leukocyte Growth Factor | [FDA Established Pharmacologic Classes] |
| Leukotriene Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Lincosamide Antibacterial | [FDA Established Pharmacologic Classes] |
| Lipid Emulsion | [FDA Established Pharmacologic Classes] |
| Lipid-based Polyene Antifungal | [FDA Established Pharmacologic Classes] |
| Lipoglycopeptide Antibacterial | [FDA Established Pharmacologic Classes] |
| Lipopeptide Antibacterial | [FDA Established Pharmacologic Classes] |
| Live Attenuated Bacillus Calmette-Guerin Immunotherapy | [FDA Established Pharmacologic Classes] |
| Live Attenuated Bacillus Calmette-Guerin Vaccine | [FDA Established Pharmacologic Classes] |
| Live Attenuated Mumps Virus Vaccine | [FDA Established Pharmacologic Classes] |
| Live Human Adenovirus Type 4 Vaccine | [FDA Established Pharmacologic Classes] |
| Live Human Adenovirus Type 7 Vaccine | [FDA Established Pharmacologic Classes] |
| Live Rotavirus Vaccine | [FDA Established Pharmacologic Classes] |
| Local Anesthetic | [FDA Established Pharmacologic Classes] |
| Loop Diuretic | [FDA Established Pharmacologic Classes] |
| Low Molecular Weight Heparin | [FDA Established Pharmacologic Classes] |
| Lymphocyte Growth Factor | [FDA Established Pharmacologic Classes] |
| Macrolide Antibacterial | [FDA Established Pharmacologic Classes] |
| Macrolide Antimicrobial | [FDA Established Pharmacologic Classes] |
| Macrolide | [FDA Established Pharmacologic Classes] |
| Mast Cell Stabilizer | [FDA Established Pharmacologic Classes] |
| Megakaryocyte Growth Factor | [FDA Established Pharmacologic Classes] |
| Melanin Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
| Melatonin Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Metal Chelator | [FDA Established Pharmacologic Classes] |
| Methylated Sulfonamide Antibacterial | [FDA Established Pharmacologic Classes] |
| Methylating Agent | [FDA Established Pharmacologic Classes] |
| Methylxanthine | [FDA Established Pharmacologic Classes] |
| Microsomal Triglyceride Transfer Protein Inhibitor | [FDA Established Pharmacologic Classes] |
| Microtubule Inhibitor | [FDA Established Pharmacologic Classes] |
| Monoamine Oxidase Inhibitor | [FDA Established Pharmacologic Classes] |
| Monoamine Oxidase Type B Inhibitor | [FDA Established Pharmacologic Classes] |
| Monobactam Antibacterial | [FDA Established Pharmacologic Classes] |
| Mood Stabilizer | [FDA Established Pharmacologic Classes] |
| mTOR Inhibitor Immunosuppressant | [FDA Established Pharmacologic Classes] |
| Mucocutaneous Epithelial Cell Growth Factor | [FDA Established Pharmacologic Classes] |
| Mucolytic | [FDA Established Pharmacologic Classes] |
| Muscle Relaxant | [FDA Established Pharmacologic Classes] |
| N-methyl-D-aspartate Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| N-type Calcium Channel Antagonist | [FDA Established Pharmacologic Classes] |
| Natriuretic Peptide | [FDA Established Pharmacologic Classes] |
| Neuraminidase Inhibitor | [FDA Established Pharmacologic Classes] |
| Nicotinic Acid | [FDA Established Pharmacologic Classes] |
| Nitrate Vasodilator | [FDA Established Pharmacologic Classes] |
| Nitrofuran Antibacterial | [FDA Established Pharmacologic Classes] |
| Nitrogen Binding Agent | [FDA Established Pharmacologic Classes] |
| Nitroimidazole Antimicrobial | [FDA Established Pharmacologic Classes] |
| Non-narcotic Antitussive | [FDA Established Pharmacologic Classes] |
| Non-Standardized Animal Dander Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Animal Hair Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Animal Skin Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Bacterial Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Chemical Allergen | [FDA Established Pharmacologic Classes] |
| Non-Standardized Feather Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Food Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Fungal Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized House Dust Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Insect Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Insect Venom Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Plant Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Plant Fiber Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Non-Standardized Pollen Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Noncompetitive AMPA Glutamate Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Nondepolarizing Neuromuscular Blocker | [FDA Established Pharmacologic Classes] |
| Nonergot Dopamine Agonist | [FDA Established Pharmacologic Classes] |
| Nonsteroidal Anti-inflammatory Drug | [FDA Established Pharmacologic Classes] |
| Norepinephrine Reuptake Inhibitor | [FDA Established Pharmacologic Classes] |
| Nucleoside Analog Antifungal | [FDA Established Pharmacologic Classes] |
| Nucleoside Analog Antiviral | [FDA Established Pharmacologic Classes] |
| Nucleoside Metabolic Inhibitor | [FDA Established Pharmacologic Classes] |
| Omega-3 Fatty Acid | [FDA Established Pharmacologic Classes] |
| Opioid Agonist | [FDA Established Pharmacologic Classes] |
| Opioid Agonist/Antagonist | [FDA Established Pharmacologic Classes] |
| Opioid Antagonist | [FDA Established Pharmacologic Classes] |
| Orexin Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Osmotic Diuretic | [FDA Established Pharmacologic Classes] |
| Osmotic Laxative | [FDA Established Pharmacologic Classes] |
| Oxaborole Antifungal | [FDA Established Pharmacologic Classes] |
| Oxazolidinone Antibacterial | [FDA Established Pharmacologic Classes] |
| Oxytocic | [FDA Established Pharmacologic Classes] |
| P2Y12 Platelet Inhibitor | [FDA Established Pharmacologic Classes] |
| Paramagnetic Contrast Agent | [FDA Established Pharmacologic Classes] |
| Parathyroid Hormone Analog | [FDA Established Pharmacologic Classes] |
| Parathyroid Hormone | [FDA Established Pharmacologic Classes] |
| Parenteral Iron Replacement | [FDA Established Pharmacologic Classes] |
| Partial Cholinergic Nicotinic Agonist | [FDA Established Pharmacologic Classes] |
| Partial Opioid Agonist | [FDA Established Pharmacologic Classes] |
| Partial Opioid Agonist/Antagonist | [FDA Established Pharmacologic Classes] |
| Pediculicide | [FDA Established Pharmacologic Classes] |
| Penem Antibacterial | [FDA Established Pharmacologic Classes] |
| Penicillin-class Antibacterial | [FDA Established Pharmacologic Classes] |
| Peroxisome Proliferator Receptor alpha Agonist | [FDA Established Pharmacologic Classes] |
| Peroxisome Proliferator Receptor gamma Agonist | [FDA Established Pharmacologic Classes] |
| Phenothiazine | [FDA Established Pharmacologic Classes] |
| Phenylalanine Hydroxylase Activator | [FDA Established Pharmacologic Classes] |
| Phosphate Binder | [FDA Established Pharmacologic Classes] |
| Phosphodiesterase 3 Inhibitor | [FDA Established Pharmacologic Classes] |
| Phosphodiesterase 4 Inhibitor | [FDA Established Pharmacologic Classes] |
| Phosphodiesterase 5 Inhibitor | [FDA Established Pharmacologic Classes] |
| Photoactivated Radical Generator | [FDA Established Pharmacologic Classes] |
| Photoenhancer | [FDA Established Pharmacologic Classes] |
| Plasma Volume Expander | [FDA Established Pharmacologic Classes] |
| Platelet Aggregation Inhibitor | [FDA Established Pharmacologic Classes] |
| Platelet-reducing Agent | [FDA Established Pharmacologic Classes] |
| Platinum-based Drug | [FDA Established Pharmacologic Classes] |
| Pleuromutilin Antibacterial | [FDA Established Pharmacologic Classes] |
| Polyene Antifungal | [FDA Established Pharmacologic Classes] |
| Polyene Antimicrobial | [FDA Established Pharmacologic Classes] |
| Polymyxin-class Antibacterial | [FDA Established Pharmacologic Classes] |
| Porphyrin Precursor | [FDA Established Pharmacologic Classes] |
| Potassium Channel Opener | [FDA Established Pharmacologic Classes] |
| Potassium Salt | [FDA Established Pharmacologic Classes] |
| Potassium-sparing Diuretic | [FDA Established Pharmacologic Classes] |
| Progesterone Agonist/Antagonist | [FDA Established Pharmacologic Classes] |
| Progesterone | [FDA Established Pharmacologic Classes] |
| Progestin Antagonist | [FDA Established Pharmacologic Classes] |
| Progestin | [FDA Established Pharmacologic Classes] |
| Progestin-containing Intrauterine Device | [FDA Established Pharmacologic Classes] |
| Programmed Death Receptor-1 Blocking Antibody | [FDA Established Pharmacologic Classes] |
| Prostacycline Vasodilator | [FDA Established Pharmacologic Classes] |
| Prostacycline | [FDA Established Pharmacologic Classes] |
| Prostaglandin Analog | [FDA Established Pharmacologic Classes] |
| Prostaglandin E1 Agonist | [FDA Established Pharmacologic Classes] |
| Prostaglandin E1 Analog | [FDA Established Pharmacologic Classes] |
| Protease Inhibitor | [FDA Established Pharmacologic Classes] |
| Protease-activated Receptor-1 Antagonist | [FDA Established Pharmacologic Classes] |
| Proteasome Inhibitor | [FDA Established Pharmacologic Classes] |
| Proton Pump Inhibitor | [FDA Established Pharmacologic Classes] |
| Provitamin D2 Compound | [FDA Established Pharmacologic Classes] |
| Psoralen | [FDA Established Pharmacologic Classes] |
| Purine Antimetabolite | [FDA Established Pharmacologic Classes] |
| Pyrethroid | [FDA Established Pharmacologic Classes] |
| Pyridone | [FDA Established Pharmacologic Classes] |
| Pyrimidine Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
| Pyrophosphate Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
| Quinolone Antimicrobial | [FDA Established Pharmacologic Classes] |
| Radioactive Diagnostic Agent | [FDA Established Pharmacologic Classes] |
| Radioactive Therapeutic Agent | [FDA Established Pharmacologic Classes] |
| Radiographic Contrast Agent | [FDA Established Pharmacologic Classes] |
| RANK Ligand Inhibitor | [FDA Established Pharmacologic Classes] |
| Recombinant Antithrombin | [FDA Established Pharmacologic Classes] |
| Recombinant Human Deoxyribonuclease 1 | [FDA Established Pharmacologic Classes] |
| Recombinant Human Growth Hormone | [FDA Established Pharmacologic Classes] |
| Recombinant Human Interferon beta | [FDA Established Pharmacologic Classes] |
| Reducing and Complexing Thiol | [FDA Established Pharmacologic Classes] |
| Renal Dehydropeptidase Inhibitor | [FDA Established Pharmacologic Classes] |
| Renin Inhibitor | [FDA Established Pharmacologic Classes] |
| Respiratory Stimulant | [FDA Established Pharmacologic Classes] |
| Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody | [FDA Established Pharmacologic Classes] |
| Retinoid | [FDA Established Pharmacologic Classes] |
| Rifamycin Antibacterial | [FDA Established Pharmacologic Classes] |
| Rifamycin Antimycobacterial | [FDA Established Pharmacologic Classes] |
| RNA Synthetase Inhibitor Antibacterial | [FDA Established Pharmacologic Classes] |
| Sclerosing Agent | [FDA Established Pharmacologic Classes] |
| Selective T Cell Costimulation Blocker | [FDA Established Pharmacologic Classes] |
| Selective T Cell Costimulation Modulator | [FDA Established Pharmacologic Classes] |
| Serotonin and Norepinephrine Reuptake Inhibitor | [FDA Established Pharmacologic Classes] |
| Serotonin Reuptake Inhibitor | [FDA Established Pharmacologic Classes] |
| Serotonin-1b and Serotonin-1d Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Serotonin-2c Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Serotonin-3 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Serotonin-4 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Sigma-1 Agonist | [FDA Established Pharmacologic Classes] |
| Skeletal Muscle Relaxant | [FDA Established Pharmacologic Classes] |
| Skin Test Antigen | [FDA Established Pharmacologic Classes] |
| Sodium-Glucose Cotransporter 2 Inhibitor | [FDA Established Pharmacologic Classes] |
| Soluble Guanylate Cyclase Stimulator | [FDA Established Pharmacologic Classes] |
| Somatostatin Analog | [FDA Established Pharmacologic Classes] |
| Sphingosine 1-phosphate Receptor Modulator | [FDA Established Pharmacologic Classes] |
| Standardized Animal Hair Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Standardized Animal Skin Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Standardized Chemical Allergen | [FDA Established Pharmacologic Classes] |
| Standardized Insect Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Standardized Insect Venom Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Standardized Pollen Allergenic Extract | [FDA Established Pharmacologic Classes] |
| Stimulant Laxative | [FDA Established Pharmacologic Classes] |
| Streptogramin Antibacterial | [FDA Established Pharmacologic Classes] |
| Substance P/Neurokinin-1 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Sucrose-specific Enzyme | [FDA Established Pharmacologic Classes] |
| Sulfonamide Antibacterial | [FDA Established Pharmacologic Classes] |
| Sulfonamide Antimicrobial | [FDA Established Pharmacologic Classes] |
| Sulfone | [FDA Established Pharmacologic Classes] |
| Sulfonylurea | [FDA Established Pharmacologic Classes] |
| Surfactant | [FDA Established Pharmacologic Classes] |
| Sympathomimetic Amine Anorectic | [FDA Established Pharmacologic Classes] |
| Sympathomimetic-like Agent | [FDA Established Pharmacologic Classes] |
| Tetracycline-class Antibacterial | [FDA Established Pharmacologic Classes] |
| Tetracycline-class Antimicrobial | [FDA Established Pharmacologic Classes] |
| Tetracycline-class Drug | [FDA Established Pharmacologic Classes] |
| Thalidomide Analog | [FDA Established Pharmacologic Classes] |
| Thiazide Diuretic | [FDA Established Pharmacologic Classes] |
| Thiazide-like Diuretic | [FDA Established Pharmacologic Classes] |
| Thiazolidinedione | [FDA Established Pharmacologic Classes] |
| Thrombolytic Agent | [FDA Established Pharmacologic Classes] |
| Thrombopoietin Receptor Agonist | [FDA Established Pharmacologic Classes] |
| Thyroid Hormone Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
| Thyroid Stimulating Hormone | [FDA Established Pharmacologic Classes] |
| Topoisomerase Inhibitor | [FDA Established Pharmacologic Classes] |
| Tricyclic Antidepressant | [FDA Established Pharmacologic Classes] |
| Tuberculosis Skin Test | [FDA Established Pharmacologic Classes] |
| Tumor Necrosis Factor Blocker | [FDA Established Pharmacologic Classes] |
| Typical Antipsychotic | [FDA Established Pharmacologic Classes] |
| Uncompetitive N-methyl-D-aspartate Receptor Antagonist | [FDA Established Pharmacologic Classes] |
| Unfractionated Heparin | [FDA Established Pharmacologic Classes] |
| Urease Inhibitor | [FDA Established Pharmacologic Classes] |
| Uric Acid-specific Enzyme | [FDA Established Pharmacologic Classes] |
| Vascular Endothelial Growth Factor Receptor 2 Antagonist | [FDA Established Pharmacologic Classes] |
| Vascular Endothelial Growth Factor-directed Antibody | [FDA Established Pharmacologic Classes] |
| Vasodilator | [FDA Established Pharmacologic Classes] |
| Vasopressin Analog | [FDA Established Pharmacologic Classes] |
| Vasopressin Antagonist | [FDA Established Pharmacologic Classes] |
| Vesicular Monoamine Transporter 2 Inhibitor | [FDA Established Pharmacologic Classes] |
| Vinca Alkaloid | [FDA Established Pharmacologic Classes] |
| Vitamin A | [FDA Established Pharmacologic Classes] |
| Vitamin B Complex Member | [FDA Established Pharmacologic Classes] |
| Vitamin B12 | [FDA Established Pharmacologic Classes] |
| Vitamin D Analog | [FDA Established Pharmacologic Classes] |
| Vitamin D | [FDA Established Pharmacologic Classes] |
| Vitamin D2 Analog | [FDA Established Pharmacologic Classes] |
| Vitamin D3 Analog | [FDA Established Pharmacologic Classes] |
| Vitamin K Antagonist | [FDA Established Pharmacologic Classes] |
| Vitamin K | [FDA Established Pharmacologic Classes] |
| Warfarin Reversal Agent | [FDA Established Pharmacologic Classes] |
| Xanthine Oxidase Inhibitor | [FDA Established Pharmacologic Classes] |
| 5-alpha Reductase Inhibitors | [Mechanism of Action] |
| 5-Lipoxygenase Inhibitors | [Mechanism of Action] |
| Acetyl Aldehyde Dehydrogenase Inhibitors | [Mechanism of Action] |
| Acetylcholine Release Inhibitors | [Mechanism of Action] |
| Acidifying Activity | [Mechanism of Action] |
| Adenosine Receptor Agonists | [Mechanism of Action] |
| Adrenal Steroid Synthesis Inhibitors | [Mechanism of Action] |
| Adrenergic Agonists | [Mechanism of Action] |
| Adrenergic alpha-Agonists | [Mechanism of Action] |
| Adrenergic alpha-Antagonists | [Mechanism of Action] |
| Adrenergic alpha1-Agonists | [Mechanism of Action] |
| Adrenergic alpha2-Agonists | [Mechanism of Action] |
| Adrenergic beta-Agonists | [Mechanism of Action] |
| Adrenergic beta-Antagonists | [Mechanism of Action] |
| Adrenergic beta1-Antagonists | [Mechanism of Action] |
| Adrenergic beta2-Agonists | [Mechanism of Action] |
| Adrenergic beta2-Antagonists | [Mechanism of Action] |
| Adrenergic beta3-Agonists | [Mechanism of Action] |
| Aldosterone Antagonists | [Mechanism of Action] |
| Alkylating Activity | [Mechanism of Action] |
| alpha Glucosidase Inhibitors | [Mechanism of Action] |
| Ammonium Ion Binding Activity | [Mechanism of Action] |
| AMPA Receptor Antagonists | [Mechanism of Action] |
| Amylin Agonists | [Mechanism of Action] |
| Androgen Receptor Agonists | [Mechanism of Action] |
| Androgen Receptor Antagonists | [Mechanism of Action] |
| Angiotensin 2 Receptor Antagonists | [Mechanism of Action] |
| Angiotensin 2 Type 1 Receptor Antagonists | [Mechanism of Action] |
| Angiotensin-converting Enzyme Inhibitors | [Mechanism of Action] |
| Antibody-Surface Protein Interactions | [Mechanism of Action] |
| Antidiuretic Hormone Antagonists | [Mechanism of Action] |
| Antigen Neutralization | [Mechanism of Action] |
| Aromatase Inhibitors | [Mechanism of Action] |
| B Lymphocyte Stimulator-directed Antibody Interactions | [Mechanism of Action] |
| Bacterial Neurotoxin Neutralization | [Mechanism of Action] |
| beta Lactamase Inhibitors | [Mechanism of Action] |
| Bile-acid Binding Activity | [Mechanism of Action] |
| Bradykinin B2 Receptor Antagonists | [Mechanism of Action] |
| Breast Cancer Resistance Protein Inhibitors | [Mechanism of Action] |
| Calcineurin Inhibitors | [Mechanism of Action] |
| Calcium Channel Antagonists | [Mechanism of Action] |
| Calcium Chelating Activity | [Mechanism of Action] |
| Carbamoyl Phosphate Synthetase 1 Activators | [Mechanism of Action] |
| Carbonic Anhydrase Inhibitors | [Mechanism of Action] |
| Catechol O-Methyltransferase Inhibitors | [Mechanism of Action] |
| Catecholamine Synthesis Inhibitors | [Mechanism of Action] |
| CD20-directed Antibody Interactions | [Mechanism of Action] |
| CD3 Receptor Antagonists | [Mechanism of Action] |
| CD3-directed Antibody Interactions | [Mechanism of Action] |
| CD30-directed Antibody Interactions | [Mechanism of Action] |
| CD52-directed Antibody Interactions | [Mechanism of Action] |
| CD80-directed Antibody Interactions | [Mechanism of Action] |
| CD86-directed Antibody Interactions | [Mechanism of Action] |
| Chemokine Co-receptor 5 Antagonists | [Mechanism of Action] |
| Chloride Channel Activation Potentiators | [Mechanism of Action] |
| Chloride Channel Activators | [Mechanism of Action] |
| Cholinergic Agonists | [Mechanism of Action] |
| Cholinergic Antagonists | [Mechanism of Action] |
| Cholinergic Muscarinic Agonists | [Mechanism of Action] |
| Cholinergic Muscarinic Antagonists | [Mechanism of Action] |
| Cholinesterase Inhibitors | [Mechanism of Action] |
| Cholinesterase Reactivators | [Mechanism of Action] |
| Competitive Opioid Antagonists | [Mechanism of Action] |
| Complement Inhibitors | [Mechanism of Action] |
| Corticosteroid Hormone Receptor Agonists | [Mechanism of Action] |
| CTLA-4-directed Antibody Interactions | [Mechanism of Action] |
| Cyclooxygenase Inhibitors | [Mechanism of Action] |
| Cystine Disulfide Reduction | [Mechanism of Action] |
| Cytochrome P450 17A1 Inhibitors | [Mechanism of Action] |
| Cytochrome P450 1A2 Inducers | [Mechanism of Action] |
| Cytochrome P450 1A2 Inhibitors | [Mechanism of Action] |
| Cytochrome P450 2B6 Inducers | [Mechanism of Action] |
| Cytochrome P450 2B6 Inhibitors | [Mechanism of Action] |
| Cytochrome P450 2C19 Inducers | [Mechanism of Action] |
| Cytochrome P450 2C19 Inhibitors | [Mechanism of Action] |
| Cytochrome P450 2C8 Inducers | [Mechanism of Action] |
| Cytochrome P450 2C8 Inhibitors | [Mechanism of Action] |
| Cytochrome P450 2C9 Inducers | [Mechanism of Action] |
| Cytochrome P450 2C9 Inhibitors | [Mechanism of Action] |
| Cytochrome P450 2D6 Inducers | [Mechanism of Action] |
| Cytochrome P450 2D6 Inhibitors | [Mechanism of Action] |
| Cytochrome P450 3A Inducers | [Mechanism of Action] |
| Cytochrome P450 3A Inhibitors | [Mechanism of Action] |
| Cytochrome P450 3A4 Inducers | [Mechanism of Action] |
| Cytochrome P450 3A4 Inhibitors | [Mechanism of Action] |
| Cytochrome P450 3A5 Inhibitors | [Mechanism of Action] |
| Decarboxylase Inhibitors | [Mechanism of Action] |
| Demulcent Activity | [Mechanism of Action] |
| Digoxin Binding Activity | [Mechanism of Action] |
| Dihydrofolate Reductase Inhibitors | [Mechanism of Action] |
| Dihydroorotate Dehydrogenase Inhibitors | [Mechanism of Action] |
| Dipeptidase Inhibitors | [Mechanism of Action] |
| Dipeptidyl Peptidase 4 Inhibitors | [Mechanism of Action] |
| DNA Polymerase Inhibitors | [Mechanism of Action] |
| DOPA Decarboxylase Inhibitors | [Mechanism of Action] |
| Dopamine Agonists | [Mechanism of Action] |
| Dopamine D2 Antagonists | [Mechanism of Action] |
| Dopamine Uptake Inhibitors | [Mechanism of Action] |
| Dyes | [Mechanism of Action] |
| Endogenous Antigen Neutralization | [Mechanism of Action] |
| Endothelin Receptor Antagonists | [Mechanism of Action] |
| Estrogen Receptor Agonists | [Mechanism of Action] |
| Estrogen Receptor Antagonists | [Mechanism of Action] |
| Factor Xa Inhibitors | [Mechanism of Action] |
| Folic Acid Metabolism Inhibitors | [Mechanism of Action] |
| Free Radical Scavenging Activity | [Mechanism of Action] |
| Full Opioid Agonists | [Mechanism of Action] |
| Fusion Protein Inhibitors | [Mechanism of Action] |
| GABA A Agonists | [Mechanism of Action] |
| GABA B Agonists | [Mechanism of Action] |
| Glucagon-like Peptide-1 (GLP-1) Agonists | [Mechanism of Action] |
| Glucosylceramide Synthase Inhibitors | [Mechanism of Action] |
| Gonadotropin Releasing Hormone Receptor Agonists | [Mechanism of Action] |
| Gonadotropin Releasing Hormone Receptor Antagonists | [Mechanism of Action] |
| Growth Hormone Receptor Antagonists | [Mechanism of Action] |
| Guanylate Cyclase Activators | [Mechanism of Action] |
| Guanylate Cyclase Stimulators | [Mechanism of Action] |
| HCV NS3/4A Protease Inhibitors | [Mechanism of Action] |
| Heparin Binding Activity | [Mechanism of Action] |
| HER1 Antagonists | [Mechanism of Action] |
| HER2/Neu/cerbB2 Antagonists | [Mechanism of Action] |
| Histamine H1 Receptor Antagonists | [Mechanism of Action] |
| Histamine H2 Receptor Antagonists | [Mechanism of Action] |
| Histamine Receptor Antagonists | [Mechanism of Action] |
| Histone Deacetylase Inhibitors | [Mechanism of Action] |
| HIV Integrase Inhibitors | [Mechanism of Action] |
| HIV Protease Inhibitors | [Mechanism of Action] |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | [Mechanism of Action] |
| Hydroxyphenylpyruvate Dioxygenase Inhibitors | [Mechanism of Action] |
| IgE-directed Antibody Interactions | [Mechanism of Action] |
| Increased Calcium-sensing Receptor Sensitivity | [Mechanism of Action] |
| Integrin Receptor Antagonists | [Mechanism of Action] |
| Interferon Inducers | [Mechanism of Action] |
| Interleukin 1 Receptor Antagonists | [Mechanism of Action] |
| Interleukin 2 Receptor Antagonists | [Mechanism of Action] |
| Interleukin 2 Receptor-directed Antibody Interactions | [Mechanism of Action] |
| Interleukin 6 Receptor Antagonists | [Mechanism of Action] |
| Interleukin-6 Antagonists | [Mechanism of Action] |
| Iron Chelating Activity | [Mechanism of Action] |
| Irrigation | [Mechanism of Action] |
| Janus Kinase Inhibitors | [Mechanism of Action] |
| Kallikrein Inhibitors | [Mechanism of Action] |
| Kinase Inhibitors | [Mechanism of Action] |
| Lead Chelating Activity | [Mechanism of Action] |
| Leukotriene Receptor Antagonists | [Mechanism of Action] |
| Lipase Inhibitors | [Mechanism of Action] |
| M2 Protein Inhibitors | [Mechanism of Action] |
| Magnesium Ion Exchange Activity | [Mechanism of Action] |
| Magnetic Resonance Contrast Activity | [Mechanism of Action] |
| Melanin Synthesis Inhibitors | [Mechanism of Action] |
| Melatonin Receptor Agonists | [Mechanism of Action] |
| Metal Chelating Activity | [Mechanism of Action] |
| Methylating Activity | [Mechanism of Action] |
| Microsomal Triglyceride Transfer Protein Inhibitors | [Mechanism of Action] |
| Monoamine Oxidase Inhibitors | [Mechanism of Action] |
| Monoamine Oxidase-B Inhibitors | [Mechanism of Action] |
| mTOR Inhibitors | [Mechanism of Action] |
| Multidrug and Toxin Extrusion Transporter 1 Inhibitors | [Mechanism of Action] |
| N-Calcium Channel Receptor Antagonists | [Mechanism of Action] |
| Neuraminidase Inhibitors | [Mechanism of Action] |
| Neurokinin 1 Antagonists | [Mechanism of Action] |
| NMDA Receptor Antagonists | [Mechanism of Action] |
| Non-Nucleoside Reverse Transcriptase Inhibitors | [Mechanism of Action] |
| Norepinephrine Uptake Inhibitors | [Mechanism of Action] |
| Nucleic Acid Synthesis Inhibitors | [Mechanism of Action] |
| Nucleoside Reverse Transcriptase Inhibitors | [Mechanism of Action] |
| Opioid Agonists | [Mechanism of Action] |
| Opioid Antagonists | [Mechanism of Action] |
| Orexin Receptor Antagonists | [Mechanism of Action] |
| Organic Anion Transporter 1 Inhibitors | [Mechanism of Action] |
| Organic Anion Transporter 3 Inhibitors | [Mechanism of Action] |
| Organic Anion Transporting Polypeptide 1B1 Inhibitors | [Mechanism of Action] |
| Organic Anion Transporting Polypeptide 1B3 Inhibitors | [Mechanism of Action] |
| Organic Cation Transporter 1 Inhibitors | [Mechanism of Action] |
| Organic Cation Transporter 2 Inhibitors | [Mechanism of Action] |
| Osmotic Activity | [Mechanism of Action] |
| P-Glycoprotein Inhibitors | [Mechanism of Action] |
| P-Glycoprotein Interactions | [Mechanism of Action] |
| P2Y12 Receptor Antagonists | [Mechanism of Action] |
| Partial Cholinergic Nicotinic Agonists | [Mechanism of Action] |
| Partial Opioid Agonists | [Mechanism of Action] |
| Peroxisome Proliferator-activated Receptor Activity | [Mechanism of Action] |
| Peroxisome Proliferator-activated Receptor alpha Agonists | [Mechanism of Action] |
| Phenylalanine Hydroxylase Activators | [Mechanism of Action] |
| Phosphate Chelating Activity | [Mechanism of Action] |
| Phosphodiesterase 3 Inhibitors | [Mechanism of Action] |
| Phosphodiesterase 4 Inhibitors | [Mechanism of Action] |
| Phosphodiesterase 5 Inhibitors | [Mechanism of Action] |
| Photoabsorption | [Mechanism of Action] |
| Positron Emitting Activity | [Mechanism of Action] |
| Potassium Channel Antagonists | [Mechanism of Action] |
| Potassium Channel Openers | [Mechanism of Action] |
| Progestational Hormone Receptor Antagonists | [Mechanism of Action] |
| Programmed Death Receptor-1-directed Antibody Interactions | [Mechanism of Action] |
| Prostaglandin Receptor Agonists | [Mechanism of Action] |
| Protease-activated Receptor-1 Antagonists | [Mechanism of Action] |
| Proteasome Inhibitors | [Mechanism of Action] |
| Protein Kinase Inhibitors | [Mechanism of Action] |
| Protein Synthesis Inhibitors | [Mechanism of Action] |
| Proton Pump Inhibitors | [Mechanism of Action] |
| Radiopharmaceutical Activity | [Mechanism of Action] |
| RANK Ligand Blocking Activity | [Mechanism of Action] |
| Receptor Tyrosine Kinase Inhibitors | [Mechanism of Action] |
| Reduction Activity | [Mechanism of Action] |
| Renin Inhibitors | [Mechanism of Action] |
| RNA Replicase Inhibitors | [Mechanism of Action] |
| RNA Synthetase Inhibitors | [Mechanism of Action] |
| Sclerosing Activity | [Mechanism of Action] |
| Selective Estrogen Receptor Modulators | [Mechanism of Action] |
| Selective Progesterone Receptor Modulators | [Mechanism of Action] |
| Serotonin 1b Receptor Agonists | [Mechanism of Action] |
| Serotonin 1d Receptor Agonists | [Mechanism of Action] |
| Serotonin 2c Receptor Agonists | [Mechanism of Action] |
| Serotonin 3 Receptor Antagonists | [Mechanism of Action] |
| Serotonin 4 Receptor Antagonists | [Mechanism of Action] |
| Serotonin Uptake Inhibitors | [Mechanism of Action] |
| Sigma-1 Receptor Agonists | [Mechanism of Action] |
| Smoothened Receptor Antagonists | [Mechanism of Action] |
| Sodium-Glucose Transporter 2 Inhibitors | [Mechanism of Action] |
| Somatostatin Receptor Agonists | [Mechanism of Action] |
| Sphingosine 1-Phosphate Receptor Modulators | [Mechanism of Action] |
| Surfactant Activity | [Mechanism of Action] |
| Thrombin Inhibitors | [Mechanism of Action] |
| Thrombopoietin Receptor Agonists | [Mechanism of Action] |
| Thyroid Hormone Synthesis Inhibitors | [Mechanism of Action] |
| Topoisomerase Inhibitors | [Mechanism of Action] |
| Trypsin Inhibitors | [Mechanism of Action] |
| Tumor Necrosis Factor alpha Receptor Blocking Activity | [Mechanism of Action] |
| Tumor Necrosis Factor Receptor Blocking Activity | [Mechanism of Action] |
| UGT1A1 Inhibitors | [Mechanism of Action] |
| UGT1A3 Inhibitors | [Mechanism of Action] |
| UGT1A4 Inhibitors | [Mechanism of Action] |
| UGT1A6 Inhibitors | [Mechanism of Action] |
| UGT1A9 Inhibitors | [Mechanism of Action] |
| UGT2B15 Inhibitors | [Mechanism of Action] |
| UGT2B7 Inhibitors | [Mechanism of Action] |
| Ultrasound Contrast Activity | [Mechanism of Action] |
| Uncompetitive NMDA Receptor Antagonists | [Mechanism of Action] |
| Urease Inhibitors | [Mechanism of Action] |
| Vascular Endothelial Growth Factor Receptor Inhibitors | [Mechanism of Action] |
| Vascular Endothelial Growth Factor-directed Antibody Interactions | [Mechanism of Action] |
| VEGFR2 Inhibitors | [Mechanism of Action] |
| Venom Neutralization | [Mechanism of Action] |
| Vesicular Monoamine Transporter 2 Inhibitors | [Mechanism of Action] |
| Virus Neutralization | [Mechanism of Action] |
| Vitamin K Inhibitors | [Mechanism of Action] |
| X-Ray Contrast Activity | [Mechanism of Action] |
| Xanthine Oxidase Inhibitors | [Mechanism of Action] |
| Actively Acquired Immunity | [Physiologic Effect] |
| Alveolar Surface Tension Reduction | [Physiologic Effect] |
| Appetite Suppression | [Physiologic Effect] |
| Arteriolar Vasodilation | [Physiologic Effect] |
| Cardiac Rhythm Alteration | [Physiologic Effect] |
| Cell-mediated Immunity | [Physiologic Effect] |
| Central Nervous System Depression | [Physiologic Effect] |
| Central Nervous System Stimulation | [Physiologic Effect] |
| Centrally-mediated Muscle Relaxation | [Physiologic Effect] |
| Decreased Autonomic Ganglionic Activity | [Physiologic Effect] |
| Decreased B Lymphocyte Activation | [Physiologic Effect] |
| Decreased Blood Pressure | [Physiologic Effect] |
| Decreased Cell Wall Integrity | [Physiologic Effect] |
| Decreased Cell Wall Synthesis & Repair | [Physiologic Effect] |
| Decreased Central Nervous System Disorganized Electrical Activity | [Physiologic Effect] |
| Decreased Central Nervous System Organized Electrical Activity | [Physiologic Effect] |
| Decreased Cholesterol Absorption | [Physiologic Effect] |
| Decreased Coagulation Factor Activity | [Physiologic Effect] |
| Decreased Copper Ion Absorption | [Physiologic Effect] |
| Decreased Cytokine Activity | [Physiologic Effect] |
| Decreased DNA Replication | [Physiologic Effect] |
| Decreased Embryonic Implantation | [Physiologic Effect] |
| Decreased Fibrinolysis | [Physiologic Effect] |
| Decreased GI Motility | [Physiologic Effect] |
| Decreased GI Smooth Muscle Tone | [Physiologic Effect] |
| Decreased Glycolysis | [Physiologic Effect] |
| Decreased GnRH Secretion | [Physiologic Effect] |
| Decreased Histamine Release | [Physiologic Effect] |
| Decreased IgE Activity | [Physiologic Effect] |
| Decreased Immunologic Activity | [Physiologic Effect] |
| Decreased Immunologically Active Molecule Activity | [Physiologic Effect] |
| Decreased Leukotriene Production | [Physiologic Effect] |
| Decreased Mitosis | [Physiologic Effect] |
| Decreased Parasympathetic Acetylcholine Activity | [Physiologic Effect] |
| Decreased Platelet Aggregation | [Physiologic Effect] |
| Decreased Platelet Production | [Physiologic Effect] |
| Decreased Prostaglandin Production | [Physiologic Effect] |
| Decreased Protein Synthesis | [Physiologic Effect] |
| Decreased Renal K+ Excretion | [Physiologic Effect] |
| Decreased Respiratory Secretion Viscosity | [Physiologic Effect] |
| Decreased RNA Replication | [Physiologic Effect] |
| Decreased Sebaceous Gland Activity | [Physiologic Effect] |
| Decreased Sperm Motility | [Physiologic Effect] |
| Decreased Striated Muscle Contraction | [Physiologic Effect] |
| Decreased Striated Muscle Tone | [Physiologic Effect] |
| Decreased Sympathetic Activity | [Physiologic Effect] |
| Decreased Tracheobronchial Stretch Receptor Activity | [Physiologic Effect] |
| Decreased Vascular Permeability | [Physiologic Effect] |
| Depigmenting Activity | [Physiologic Effect] |
| Digestive/GI System Activity Alteration | [Physiologic Effect] |
| Emesis Suppression | [Physiologic Effect] |
| General Anesthesia | [Physiologic Effect] |
| Genitourinary Arterial Vasodilation | [Physiologic Effect] |
| GI Motility Alteration | [Physiologic Effect] |
| Hematologic Activity Alteration | [Physiologic Effect] |
| Increased Acetylcholine Activity | [Physiologic Effect] |
| Increased Blood Pressure | [Physiologic Effect] |
| Increased Cellular Death | [Physiologic Effect] |
| Increased Coagulation Activity | [Physiologic Effect] |
| Increased Coagulation Factor Activity | [Physiologic Effect] |
| Increased Coagulation Factor IX Activity | [Physiologic Effect] |
| Increased Coagulation Factor VIII Activity | [Physiologic Effect] |
| Increased Coagulation Factor VIII Concentration | [Physiologic Effect] |
| Increased Coagulation Factor X Activity | [Physiologic Effect] |
| Increased Cytokine Activity | [Physiologic Effect] |
| Increased Cytokine Production | [Physiologic Effect] |
| Increased Diuresis at Loop of Henle | [Physiologic Effect] |
| Increased Diuresis | [Physiologic Effect] |
| Increased Dopamine Activity | [Physiologic Effect] |
| Increased Epithelial Proliferation | [Physiologic Effect] |
| Increased Erythroid Cell Production | [Physiologic Effect] |
| Increased Fibrin Polymerization Activity | [Physiologic Effect] |
| Increased GHRH Activity | [Physiologic Effect] |
| Increased Gluconeogenesis | [Physiologic Effect] |
| Increased Glutathione Concentration | [Physiologic Effect] |
| Increased Glycogenolysis | [Physiologic Effect] |
| Increased Hematopoietic Stem Cell Mobilization | [Physiologic Effect] |
| Increased Histamine Release | [Physiologic Effect] |
| Increased IgG Production | [Physiologic Effect] |
| Increased Immunologically Active Molecule Activity | [Physiologic Effect] |
| Increased Intravascular Volume | [Physiologic Effect] |
| Increased Large Intestinal Motility | [Physiologic Effect] |
| Increased Lymphocyte Activation | [Physiologic Effect] |
| Increased Lymphocyte Cell Production | [Physiologic Effect] |
| Increased Macrophage Proliferation | [Physiologic Effect] |
| Increased Medullary Respiratory Drive | [Physiologic Effect] |
| Increased Megakaryocyte Maturation | [Physiologic Effect] |
| Increased Myeloid Cell Production | [Physiologic Effect] |
| Increased Norepinephrine Activity | [Physiologic Effect] |
| Increased Oncotic Pressure | [Physiologic Effect] |
| Increased Platelet Aggregation | [Physiologic Effect] |
| Increased Platelet Production | [Physiologic Effect] |
| Increased Prostaglandin Activity | [Physiologic Effect] |
| Increased Prothrombin Activity | [Physiologic Effect] |
| Increased Sympathetic Activity | [Physiologic Effect] |
| Increased T Lymphocyte Activation | [Physiologic Effect] |
| Increased T Lymphocyte Destruction | [Physiologic Effect] |
| Increased Thrombolysis | [Physiologic Effect] |
| Increased Uterine Smooth Muscle Contraction or Tone | [Physiologic Effect] |
| Inhibit Ovum Fertilization | [Physiologic Effect] |
| Local Anesthesia | [Physiologic Effect] |
| Lymphocyte Function Alteration | [Physiologic Effect] |
| Microtubule Inhibition | [Physiologic Effect] |
| Neuromuscular Depolarizing Blockade | [Physiologic Effect] |
| Neuromuscular Nondepolarizing Blockade | [Physiologic Effect] |
| Passively Acquired Immunity | [Physiologic Effect] |
| Photosensitizing Activity | [Physiologic Effect] |
| Reversed Anticoagulation Activity | [Physiologic Effect] |
| Skin Barrier Activity | [Physiologic Effect] |
| Stimulation Large Intestine Fluid/Electrolyte Secretion | [Physiologic Effect] |
| T Lymphocyte Costimulation Activity Blockade | [Physiologic Effect] |
| Vascular Sclerosing Activity | [Physiologic Effect] |
| Vasodilation | [Physiologic Effect] |
| Venous Vasodilation | [Physiologic Effect] |